Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis

Triple-negative breast cancer (TNBC) harbors a high percentage of breast cancer stem-like cells (BCSCs) that significantly contribute to poor prognosis, metastasis, and relapse of the disease. Thus, targeting BCSCs could be a promising approach to combat TNBC. In this context, we investigated nimbol...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Priyanka Mohapatra, Swati Madhulika, Somalisa Behera, Priya Singh, Pratikshya Sa, Punit Prasad, Rajeeb Kumar Swain, Sanjeeb Kumar Sahoo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2023-12-01
Serie:	Molecular Therapy: Nucleic Acids
Soggetti:	MT: Delivery Strategies triple-negative breast cancer cancer stem cells nanomedicine nimbolide epigenetics
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2162253123002445
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!